Aitken, Dawn http://orcid.org/0000-0001-5685-7634
Laslett, Laura L.
Cai, Guoqi
Hill, Catherine
March, Lyn
Wluka, Anita E.
Wang, Yuanyuan
Blizzard, Leigh
Cicuttini, Flavia
Jones, Graeme
Funding for this research was provided by:
National Health and Medical Research Council (APP1045415)
Article History
Received: 2 May 2018
Accepted: 19 June 2018
First Online: 18 July 2018
Ethics approval and consent to participate
: Ethics approval has been obtained from the Tasmania Health and Medical Human Research Ethics Committee (H0012941), The Alfred Hospital Ethics Committee (03/13), Monash University Human Research Ethics Committee (CF14/1064–2,014,000,452), Northern Sydney Local Health District Ethics Committee (HREC/13/HAWKE/80) and Human Research Ethics Committee (TQEH/LMH/MH) (HREC/13/TQEHLMH/134). Written informed consent will be obtained from all patients by the study doctor (i.e. a rheumatologist or supervised rheumatology advanced registrar).
: Not applicable.
: Voltarra Pharmaceuticals provided part funding for the VOLT01 sub-study but has no role in the design, implementation, data collection, data analysis, interpretation of data, or writing of the manuscript related to this study. Anita Wluka and Flavia Cicuttini are members of the Editorial Board of BMC Musculoskeletal Disorders. None of the other authors have any competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.